Ventyx Biosciences, Inc. (VTYX)
 NASDAQ: VTYX · Real-Time Price · USD
 8.42
 +1.05 (14.25%)
  At close: Oct 30, 2025, 4:00 PM EDT
8.34
 -0.08 (-0.95%)
  After-hours: Oct 30, 2025, 7:59 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $600.42 million as of October 30, 2025. Its market cap has increased by 263.08% in one year.
Market Cap 
 600.42M
Enterprise Value 
 401.75M
1-Year Change 
 263.08%
Ranking 
 Category 
 Stock Price 
$8.42
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $600.42M, a decrease of -23.31%. That is a compound annual growth rate of -6.38%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 525.54M | 239.38% | 
| Dec 31, 2024 | 154.86M | 6.21% | 
| Dec 29, 2023 | 145.80M | -92.15% | 
| Dec 30, 2022 | 1.86B | 85.92% | 
| Dec 31, 2021 | 998.89M | 27.59% | 
| Oct 21, 2021 | 782.89M | - | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 754.38B | 
| Johnson & Johnson | 453.16B | 
| AbbVie | 404.06B | 
| UnitedHealth Group | 313.44B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 217.85B |